SEC Form 4 research
| Issuer | Corbus Pharmaceuticals Holdings, Inc. |
|---|---|
| Tickers | CRBP |
| Reporting owners | 29 |
| Officers and directors | 16 |
| Last public filing | 2026-09-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-15 | 2026-09-14 | Ben Yong | S | 2,000 | $7.84 | Not reported |
| 2026-08-17 | 2026-08-16 | Nicacio Leonardo Viana | A | 58,333 | $0 | Not reported |
| 2026-08-17 | 2026-08-16 | Nicacio Leonardo Viana | A | 191,676 | $0 | Not reported |
| 2026-08-12 | 2026-08-11 | Saxena Nishant C | P | 2,600 | $9.63 | Not reported |
| 2026-08-10 | 2026-08-07 | Cohen Yuval | S | 17,000 | $10.08 | Not reported |
| 2026-08-10 | 2026-08-07 | Moran Sean F. | S | 12,000 | $10.08 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.